TY - JOUR
T1 - Chronic pelvic pain syndrome
T2 - Highlighting medicinal plants toward biomolecules discovery for upcoming drugs formulation
AU - Salehi, Bahare
AU - Butnariu, Monica
AU - Corneanu, Mihaela
AU - Sarac, Ioan
AU - Vlaisavljevic, Sanja
AU - Kitic, Dusanka
AU - Rahavian, Amirhossein
AU - Abedi, Amirreza
AU - Karkan, Morteza F.
AU - Bhatt, Indra D.
AU - Jantwal, Arvind
AU - Sharifi-Rad, Javad
AU - Rodrigues, Célia F.
AU - Martorell, Miquel
AU - Martins, Natália
N1 - Publisher Copyright:
© 2019 John Wiley & Sons, Ltd.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Chronic pelvic pain syndrome (CPPS) can be triggered by a various types of gynecological, gastrointestinal, urological, and musculoskeletal disorders. Recently, the role of the central nervous system has proven to be an integral part on the development of any chronic pain syndrome, including CPPS. However, owing to the complex and heterogeneous etiology and pathophysiology of CPPS, the establishment of effective therapeutic interventions remains challenging for both physicians and patients. Nonetheless, recent studies have pointed that medicinal plants and their secondary metabolites can be effectively used in CPPS therapy, besides contributing to restore the patients' quality of life and potentiate the conventional CPPS management. In this sense, this review aims to provide a careful overview on the biomedical data for the use of medicinal plants use and their secondary metabolites on CPPS management.
AB - Chronic pelvic pain syndrome (CPPS) can be triggered by a various types of gynecological, gastrointestinal, urological, and musculoskeletal disorders. Recently, the role of the central nervous system has proven to be an integral part on the development of any chronic pain syndrome, including CPPS. However, owing to the complex and heterogeneous etiology and pathophysiology of CPPS, the establishment of effective therapeutic interventions remains challenging for both physicians and patients. Nonetheless, recent studies have pointed that medicinal plants and their secondary metabolites can be effectively used in CPPS therapy, besides contributing to restore the patients' quality of life and potentiate the conventional CPPS management. In this sense, this review aims to provide a careful overview on the biomedical data for the use of medicinal plants use and their secondary metabolites on CPPS management.
KW - chronic pelvic pain syndrome
KW - medicinal plants
KW - preclinical and clinical studies
KW - secondary metabolites
UR - https://www.scopus.com/pages/publications/85076292413
U2 - 10.1002/ptr.6576
DO - 10.1002/ptr.6576
M3 - Artículo de revisión
C2 - 31799719
AN - SCOPUS:85076292413
SN - 0951-418X
VL - 34
SP - 769
EP - 787
JO - Phytotherapy Research
JF - Phytotherapy Research
IS - 4
ER -